Literature DB >> 10446693

The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.

S Gürel1, E Dolar, O Yerci, B Samli, H Oztürk, S G Nak, M Gülten, F Memik.   

Abstract

Gastric carcinoma is one of the most common carcinomas and a leading cause of death from cancer in Turkey. The relationship between clinicopathological features of the disease and oncogenes is under investigation. In this retrospective study we investigated the relationships between expression of c-erbB-2 oncoprotein and grade, stage and pathological characteristics of the tumour, and prognosis. Formalin-fixed, paraffin-embedded tissue sections were prepared from gastrectomy specimens from 55 patients with gastric carcinoma. The tissue sections were stained immunohistochemically to reveal c-erbB-2 protein. Six (10%) of the tumours stained positively for c-erbB-2 protein. There was no statistically significant association (P > 0.5) between c-erbB-2 staining and tumour grade, stage or pathological characteristics (necrosis, lymph-node infiltration), or between staining and prognosis. The results suggest that overexpression of c-erb-B-2 protein is not related to the pathological characteristics of the tumour in gastric carcinoma and is not an important prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446693     DOI: 10.1177/030006059902700203

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  11 in total

1.  Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients.

Authors:  N-Lale Satiroglu-Tufan; Ferda Bir; Nese Calli-Demirkan
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

2.  Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

Authors:  Hai-Zhen Dang; Yang Yu; Shun-Chang Jiao
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

3.  Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.

Authors:  Shi-Yan Yan; Ying Hu; Jian-Gao Fan; Guo-Quan Tao; Yong-Ming Lu; Xu Cai; Bao-Hua Yu; Yi-Qun Du
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions.

Authors:  Jie Wang; David S Chi; George B Kalin; Christina Sosinski; Lou Ellen Miller; Izabela Burja; Eapen Thomas
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer.

Authors:  Muharrem Bayrak; Omer Fatih Olmez; Ender Kurt; Erdem Cubukcu; Turkkan Evrensel; Ozkan Kanat; Osman Manavoglu
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

6.  Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.

Authors:  José Cangiano; Barbara A Centeno; Christopher R Garrett; William Cáceres; Ana de Jesús; Ji-Hyun Lee; Orestes Pavía; Richard Jove; Luis Báez; Daniel M Sullivan; Carlos A Muro-Cacho; Teresita Muñoz-Antonia
Journal:  Dig Dis Sci       Date:  2008-01-26       Impact factor: 3.199

7.  A novel gene, GCRG224, is differentially expressed in human gastric mucosa.

Authors:  Gang-Shi Wang; Meng-Wei Wang; Ben-Yan Wu; Wei-Di You; Xin-Yan Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

8.  HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer.

Authors:  Carlos Gómez-Martin; Elena Garralda; M José Echarri; Anabel Ballesteros; Alberto Arcediano; José Luis Rodríguez-Peralto; Manuel Hidalgo; Fernando López-Ríos
Journal:  J Clin Pathol       Date:  2012-05-08       Impact factor: 3.411

9.  The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas.

Authors:  J Ansari; A Chehrei; M Amini; S H Alizade; M H Sanei
Journal:  Iran J Cancer Prev       Date:  2011

10.  Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Hai-Ning Chen; Jian-Ping Liu; Du He; Yang Liu; Kai Liu; Xiao-Long Chen; Xian-Ming Mo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.